AstraZeneca teams up with N-SIDE for trial work

AstraZeneca facility at The Cove
AstraZeneca facility at the Cove in San Francisco (AstraZeneca)

Britain-based Big Pharma AstraZeneca has penned a new collab with Belgium’s N-SIDE for its clinical studies.

AZ will use N-SIDE’s cloud-based software for its tests, giving it "centralized management, real-time trial monitoring and results visualization," the firm said in a statement.

The company told FierceCRO that: "The N-SIDE Suite for clinical trials supports strategic decision making throughout the clinical trial process, enabling clinical trial managers to future proof their supply chain management while also reducing cost, waste and risk."


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Specifically, AZ will use the N-SIDE “Supply and Dashboard Apps” to design, plan and monitor their clinical trial supply chain.

John Murray, supply chain transformation lead at AstraZeneca, said: "N-SIDE’s Suite provides a tremendous opportunity for AstraZeneca to collaborate across key areas of clinical development and deliver the best studies for our patients."

"We are proud to further our collaboration with AstraZeneca as they implement the N-SIDE Suite for Clinical Trials to manage their clinical supply chain," stated Jacques Parlongue, N-SIDE CEO.

This new deal builds on the consulting services the firm has done for AstraZeneca’s clinical trial supply optimization since 2017.

Suggested Articles

Oncology is clearly a major medical and societal issue, but one that sees too much focus from biopharmas at the expense of other killers.

The Mayo Clinic tapped data analytics firm nference to build out an AI-powered engine to collate its years of clinical records and pathology work.

At the annual J.P. Morgan Healthcare Conference, major CRO Charles River Laboratories and Takeda announced a new preclinical tie-up.